The effect of Entikawei in the treatment of hopatitis B virus associated glomerulonephritis (HBV-GN)

Kan Xiao; Shi ZhaoZhang; Zheng ZhaoMin; Han ShaoLei

Issue 6

Jun. 2008

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2008 > 24(6): 426-427

PDF( 96 KB)

恩替卡韦治疗乙肝相关性肾炎临床观察

Published Date: 2008-06-20

Abstract

Abstract

Objective To study the effect of Entikawei in the treatment of hepatitis B Virus associated glomerulonephritis (HBV-GN) .Methods 78 patients with the diagnosis of hepatitis B Virus associated glomerulonephritis were randomly divided into 2 groups.One group was given Entikawei 0.5mg, qd, based on other conclusive treatment, while the control group was given the same treatment but without Entikawei.The patients' liver function, HBV-M, HBV-DNA were investigated after treatment for 3 months.Results Significant differences were found between the 2 groups in the liver function change, HBeAg and HBV-DNA loss or seroconversion.Conclusions Clinical situation of HBV-GN is similar with primary glomerulonephritis.It is the most useful that the treatment with Entikawei for patients with HBV-GN.
- Entikawei,
- HBV DNA positive,
- hepatitis B Virus associated glomerulonephritis

FullText(HTML)

References(11)

References

[1]刘刚, 马序竹, 邹万忠, 等.肾活检患者肾脏病构成十年对比分析[J].临床内科杂志, 2004, 21 (12) :834-838.

[2]中华内科杂志编委会.乙型肝炎病毒相关性肾炎座谈会纪要[J].中华内科杂志, 1990, 29 (9) :519-521.

[3]Combes B, Shorey J, Barrera A, et al.Glomerulonephritis with dep-osition of Aust ralia antigen antibody complexes in glomerular base-ment memberane[J].Lancet, 1971, 2 (7718) :234.

[4]Lai KN, Lai FM, TamJ S, et al.IgA nephropathy associated with Chronic hepatitis B Virus infection in adults:the pathogenetic ole of HBsAg[J].Pathol, 1989, 157 (4) :321.

[5]Lai KN, Lai FM, TamTS, et al.Strong association Between IgANe-phropathy and hepatitis B surface antigenemia in endemic areas[J].CLin Nephrol, 1988, 29:229.

[6] 张爱平.乙型肝炎病毒 (HBV) 相关性肾炎患者肾活检组织中HBVDNA分布的分子生物学检测[J].中华实验和临床病毒学杂志, 1997, 11 (3) :237-239.

[7]Bhimma R, Coovadia HM.Hepatitis B Virus associated nephropathy[J].Am J Nephrol, 2004, 24 (2) :198-211.

[8]Taskapan H, Oymak O, Dogukan A, et al.Transformation of hepati-tis B virus-related membraneous glomerulonephritis to crescentic form[J].Clin Nephrol, 2000, 54 (2) :161-163.

[9]Seifer M, Hamatake RK, Colomo RJ, et al.In vitro inhibition of he-padnavirus polymerases by the triphosphates of BMS-200475and lobucavir[J].Antimicrob Agents Chemother, 1998, 42 (12) :3200-3203.

[10]Ulim F.NewInsight on hepatitis B Virus persistence from the study of intrahepatic viral cccDNA[J].Hepatol, 2005, 42:302-308.

[11]Lai CL.Entecavir (ETV) demonstrates superior histologic and viro-logic efficacy over Lamivudine (LVD) in nucleosidenaive HBeAg (-) chronic hepatitis B:results of phase3Trial ETV-027[R].55thAnnual Meeting of the American Society for the Study of Liver Diseases, Boston, 2004.

Relative Articles

[1]	Wang HongSha, Wei Qi, Lei ManMan, Jin QingLong, Wen XiaoYu, Guo YuYing. Acute hepatitis B complicated by EB virus infection: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 725-727. doi: 10.3969/j.issn.1001-5256.2017.04.026
[2]	Zhu Peng, Tang Yi, Wang YuMing. Recommendations for APASL Clinical Practice Guidelines: management of hepatitis B (updated in 2015)[J]. Journal of Clinical Hepatology, 2016, 32(3): 423-428. doi: 10.3969/j.issn.1001-5256.2016.03.004
[3]	Li Jun. Clinical research progress in integrated traditional Chinese and Western medicine therapy for HBV-related liver failure[J]. Journal of Clinical Hepatology, 2015, 31(1): 42-47. doi: 10.3969/j.issn.1001-5256.2015.01.010
[4]	Sun YuMei, Zhou YingXia, Xing HuiChun, Lin KeKe. Clock drawing test in cognitive assessment for patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 413-417. doi: 10.3969/j.issn.1001-5256.2015.03.024
[5]	Xu Ying, Liu Yu, Sun Jian. Key points of the AASLD′s guidelines on hepatitis B diagnosis and treatment[J]. Journal of Clinical Hepatology, 2013, 29(2): 162-169.
[6]	Yan Tao, Li Fan, Li Ke, Zhao Ping, Wang HuiFen. Analysis of mutational patterns of the pre-C/C region of with hepatitis B virus in patients with HBV-associated acute-on-chronic liver failure [J]. Journal of Clinical Hepatology, 2013, 29(2): 120-123+127.
[7]	Jiang LiSheng, Li YongGuo, Chen Shu, Lan YingHua. Short-term and long-term efficacy of antiviral treatment of patients with HBV-associated acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2013, 29(2): 110-113.
[8]	Cao Xiao, Cao QingBao, Zhang GuoQiang, Chang ZaiJuan, Li ShuPing, Xu WeiWei. Analysis of occult hepatitis B virus infection among blood donors in Tangshan, China[J]. Journal of Clinical Hepatology, 2013, 29(2): 117-119.
[9]	Zhang Tao, Sun KeWei. Experience and progresses of Chinese medicine therapy for hepatitis B-associated liver failure[J]. Journal of Clinical Hepatology, 2012, 28(3): 169-171+182.
[10]	Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755.
[11]	Wang XiaoJing, Ning Qin. Prospect and progression on severe acute exacerbation of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2012, 28(6): 401-404+412.
[12]	Hu XiaoLi, Zhao HongWei, Wu XiaoYan, Niu JunQi. Prevalence of hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(6): 413-416+421.
[13]	Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473.
[14]	Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673.
[15]	Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165.
[16]	Zhao YanJuan, Ye ChunYan, Song XiaoDan. The change in serum thyroid hormone levels in acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(2): 161-162+165.
[17]	Gu MaoLin, Wang XingLiang, Wu TingTing. Detection of HBV-LP and relationships between HBV DNA and its level in HBV patients with different patterns of HBV Markers[J]. Journal of Clinical Hepatology, 2011, 27(8): 810-812.
[18]	Yu Hui. Advances in epidemiology, diagnosis and treatment of hepatitis B in children[J]. Journal of Clinical Hepatology, 2011, 27(7): 687-689.
[19]	Liu Li, Hu XiaoXuan. A report of severe hepatitis with wilson desease and hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(6): 657+66.
[20]	Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2689) PDF downloads(994)

恩替卡韦治疗乙肝相关性肾炎临床观察

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

恩替卡韦治疗乙肝相关性肾炎临床观察

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content